Michael Hyun-ook Kim, MD, MMM
Chair, Department of Medicine
Professor

Contact
School of Medicine
Department of Medicine
Cardiology Division
CUMC - Creighton University Medical Center
Michael Hyun-ook Kim, MD, MMM
Chair, Department of Medicine
Professor
Teaching Interests
- Cardiac Electrophysiology
Research Focus
Cardiovascular Outcomes and Arrhythmias; atrial fibrillation; stroke; ICD therapy; health care disparities; anticoagulationDepartment
Medicine
Position
Professor
Articles
- Expert Review Pharmacoeconomics Outcomes Research
Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States, p. 1-9 2022 - J American Heart Association
US Antiarrhythmic drug treatment for patients with atrial fibrillation: an insurance claims-based approach.
10, p. e016792 2021 - Sr Care Pharm
Practical Insights into Anticoagulation for an Aging Population
35, p. 150 2020 - Advances in Therapy
Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: an analysis using Administrative Claims Data
35 (11), p. 1-122069-2080 2018 - Journal of the American College of Cardiology:Clinical Electrophysiology
Hospitalization and costs in primary prevention ICD recipients: who determines the outcomes?
4 (2), p. 254-256 2018 - Advances in Therapy
Impact of warfarin on atrial fibrillation outcomes related to economic consumption patterns: hospitalization, cost, and mortality may be predictable and modifiable at the population level
33 (9), p. 1579-1599 2016 - Journal of Innovations in Cardiac Rhythm Management
Patterns of dofetilide use for the treatment of atrial fibrillation
7, p. 2425-2428 2016 - Journal of Managed Care & Specialty Pharmacy
A call for appropriate evidence and outcomes-based use and measurement of anticoagulation for atrial fibrillation: moving the population towards improved health via multiple stakeholders
21 (11), p. 1034-1038 2015 - Heart Rhythm Case Reports
A case series of anomalous high pacing lead impedances in normally functioning leads
1 (6), p. 449-452 2015 - Heart Rhythm
Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions
12 (8), p. 1728-1736 2015 - Journal of the American College of Cardiology
Shared risk factors for anticoagulation in nonvalvular atrial fibrillation: a dilemma in clinical decision making
63 (20), p. 2148-2150 2014 - Journal of Managed Care Pharmacy
Health care burden of dyspepsia among nonvalvular atrial fibrillation patients
20 (4), p. 391-399 2014 - Advances in Therapy
Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter
31 (3), p. 318-332 2014 - International Journal of Clinical Cardiology
Cardiac troponin assessment following atrial fibrillation ablation: implications for chest pain evaluation
1 (2) 2014 - Journal of Interventional Cardiac Electrophysiology
The relationship between defibrillation threshold and total mortality
38 (3), p. 203-208 2013 - Journal of Interventional Cardiac Electrophysiology
Prospective evaluation of cinefluoroscopy and chest radiography for Riata lead defects: implications for future lead screening
38 (2), p. 131-135 2013 - Journal of Interventional Cardiac Electrophysiology
Effectiveness of VF induction with DC Fibber versus conventional induction methods in patients on chronic amiodarone therapy
38 (2), p. 137-141 2013 - Heart Rhythm
Device advisory letters: readability and comprehension, patient-centered outcomes not to be "misunderstood"
10 (4), p. 508-509 2013 - Journal of the American College of Cardiology
Treatment targets in atrial fibrillation: "is feeling better good enough?"
61, p. 461-462 2013 - Journal of Cardiovascular Electrophysiology
Prevalence and predictors of cable extrusion and loss of electrical integrity with the Riata defibrillator lead
23 (11), p. 1207-1212 2012 - Journal of Cardiovascular Electrophysiology
Catheter ablation of atrial fibrillation in Octogenarians: the Right "medicine?"
23 (7), p. 694-696 2012 - Expert Review of Clinical Pharmacology
Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation
5 (2), p. 163-171 2012 - Journal of Innovations in Cardiac Rhythm Management
Concepts in disease progression of atrial fibrillation and implications for medical management
3, p. 697-712 2012 - Journal of Cardiovascular Electrophysiology
Long-term insertable loop monitors: how much should we watch to get an answer (diagnosis)?
23 (1), p. 72-73 2012 - Clinical Therapeutics
One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis
33 (11), p. 1668-1681 2011 - Circulation: Cardiovascular Quality and Outcomes
Estimation of total incremental health care costs in patients with atrial fibrillation in the United States
4 (3), p. 313-320 2011 - Heart Rhythm
A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy
8 (5), p. 685-691 2011 - Journal of Cardiovascular Electrophysiology
Predicting the risk of heart failure events and subsequent mortality: what doth the seer know?
21 (11), p. 1224-1225 2010 - Advances in Therapy
Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States
27 (9), p. 600-612 2010 - Journal of Interventional Cardiac Electrophysiology
The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation: the Vitatron Selection AFm Registry Study
28 (3), p. 227-234 2010 - Pacing and Clinical Electrophysiology
Predictors of early mortality in patients age 80 and older receiving implantable defibrillators
33 (8), p. 981-987 2010 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Patterns and predictors of discontinuation of rhythm control drug therapy in patients with newly diagnosed atrial fibrillation
29 (12), p. 1417-1426 2009 - Current Medical Research and Opinion
Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
25 (12), p. 3037-3047 2009 - Advances in Therapy
Cost of atrial fibrillation in United States managed care organizations
26 (9), p. 847 2009 - Journal of Cardiovascular Electrophysiology
Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy
20 (8), p. 894-900 2009 - Advances in Therapy
National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US
26 (8), p. 784-794 2009 - Journal of Cardiovascular Electrophysiology
A novel method for sinus node modification and phrenic nerve protection in resistant cases
20 (6), p. 689-691 2009 - Current Medical Research and Opinion
Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation
25 (5), p. 1215-1220 2009 - Annals of Pharmacotherapy
Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation
43 (5), p. 840-848 2009 - Journal of Electrocardiology
Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual chamber pacemakers
42 (2), p. 128-135 2009 - Journal of cardiovascular nursing
A written policy increases compliance with guidelines for therapeutic anticoagulation prior to elective direct current cardioversion of atrial fibrillation
22 (5), p. 417-421 2007 - Journal of Cardiovascular Electrophysiology
A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy
18 (5), p. 490-496 2007 - Pacing and Clinical Electrophysiology
Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: an opportunity to improve rates of warfarin utilization
30 (4), p. 580-583 2007 - Occupational and Environmental Medicine
Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air polllutants in the St. Louis, Missouri metropolitan area
63 (9), p. 591-596 2006 - Heart Rhythm
Left bundle branch block during orthodromic reciprocating tachycardia: where is the accessory pathway?
3 (5), p. 610-611 2006 - Journal of Heart and Lung Transplantation
Cardiac resynchronization therapy: a potential option for congenitally corrected transposition of the great vessels
24 (12), p. 2293-2296 2005 - Pacing and Clinical Electrophysiology
Polymorphic ventricular tachycardia with a normal QT interval following azithromycin
28 (11), p. 1221-1222 2005 - Annals of Internal Medicine
Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis
143 (5), p. 327-336 2005 - Archives of Internal Medicine
Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
165 (10), p. 1185-1191 2005 - The Lancet
Cardiac pacing: the state of the art
364, p. 1701-1719 2004 - Cardiac Electrophysiology Review
Low molecular weight heparin in atrial fibrillation management: facts, fiction, future
7 (4), p. 397-400 2003 - Journal of Interventional Cardiac Electrophysiology
Diagnostic value of single versus dual chamber electrograms recorded from an implantable defibrillator
9 (1), p. 49-53 2003 - Journal of the American College of Cardiology
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
42 (1), p. 20-29 2003 - American Heart Journal
Use patterns of low molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation
145 (4), p. 665-669 2003 - Annals of Emergency Medicine
A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low molecular weight heparin
40 (2), p. 187-192 2002 - Pacing and Clinical Electrophysiology
The immediate reproducibility of T wave alternans during bicycle exercise
25 (8), p. 1185-1191 2002 - American Journal of Cardiology
Effect of amiodarone +/- diltiazem +/- beta-blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting
89 (9), p. 1126-1128 2002 - International Journal of Cardiology
Atrial fibrillation after coronary surgery: comparison between different health care systems
82 (3), p. 209-218 2002 - Journal of Cardiovascular Electrophysiology
Kearns-Sayre Syndrome: association with Long QT syndrome?
13 (2), p. 184-185 2002 - Cardiology Review
Importance of limiting atrial fibrillation after heart surgery
19 (1), p. 19-23 2002 - American Journal of Cardiology
Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin anticoagulation before elective cardioversion of atrial fibrillation or flutter
88 (12), p. 1428-1431 2001 - American Journal of Cardiology
Clinical outcomes and costs associated with a first episode of uncomplicated atrial fibrillation presenting to the emergency room
88 (1), p. 74-76 2001 - American Heart Journal
Prevalence of central venous occlusion in patients with chronic defibrillator leads
141 (5), p. 813-816 2001 - American Heart Journal
Postoperative atrial fibrillation after heart surgery: what are the goals of prevention?
141 (5), p. 691-693 2001 - American Journal of Cardiology
Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (the postoperative atrial fibrillation in cardiac surgery study (PACS2)
87 (7), p. 881-885 2001 - Journal of Cardiovascular Electrophysiology
Electrogram polarity and cavotricuspid isthmus block during ablation of typical atrial flutter
12 (4), p. 393-399 2001 - International Journal of Cardiology
Cardiac risk assessment in noncardiac thoracic surgery
13 (2), p. 137-146 2001 - American Journal of Cardiology
Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation
87 (5), p. 649-651 2001 - Congestive Heart Failure
Diastolic dysfunction in the presence of left ventricular systolic dysfunction: implications of beta-adrenergic blocking therapy
7 (2), p. 71-76 2001 - Cardiovascular Reviews and Reports
Pharmacologic and nonpharmacologic approaches to the prevention of atrial fibrillation after heart surgery
22 (5), p. 292-296 2001 - Journal of Cardiovascular Pharmacology and Therapeutics
Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment
5 (4), p. 259-266 2000 - Circulation
Effects of digoxin on acute, atrial fibrillaton-induced changes in atrial refractoriness
102 (20), p. 2503-2508 2000 - Journal of the American College of Cardiology
Diagnostic value of tachycardia features and pacing maneuvers during paroxsymal supraventricular tachycardia
36 (2), p. 574-582 2000 - Journal of Cardiovascular Electrophysiology
Effect of chronic amiodarone therapy on defibrillation energy requirements in humans
11 (7), p. 736-740 2000 - Journal of Cardiovascular Electrophysiology
Prevalence and significance of exit block during arrhythmias arising in pulmonary veins
11 (4), p. 379-386 2000 - Journal of Cardiovascular Electrophysiology
Comparison of endocardial activation times at effective and ineffective ablation sites within pulmonary veins
11 (2), p. 155-159 2000 - American Journal of Cardiology
Outcome of men with ischemic cardiomyopathy, asymptomatic nonsustained ventricular tachycardia, and negative electrophysiology studies
85 (1), p. 119-121 2000 - American Journal of Cardiology
Electrocardiographic predictors of successful ablation of tachycardia or bigeminy arising in the right ventricular outflow tract
84 (10), p. 1266-1268 1999 - Circulation
Bayesian persuasion
100 (16), p. e68-e72 1999 - Circulation
Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy
100 (7), p. 729-735 1999 - American Journal of Cardiology
Effect of electrode polarity on the energy required for transthoracic atrial defibrillation
84 (2), p. 228-230 1999 - Journal of Cardiovascular Electrophysiology
Target temperatures of 48 degrees celsius versus 60 degrees celsius during slow pathway ablation: a randomized comparison
10 (6), p. 799-803 1999 - Circulation
Sudden death in a 55-year-old woman with systemic lupus erythematosus
98 (3), p. 271-275 1998 - Clinical Cardiology
Silent ischemic cardiomyopathy and left coronary ostial stenosis secondary to radiation therapy
19 (7), p. 602 1996
Publications
- Circulation: Cardiovascular Quality and Outcomes
Impact of health related social needs on sex-based differences in hospital readmissions for atrial fibrillation
15.suppl_1, p. A68 2022 - J American College of Cardiology
Regularization of ventricular activation during atrial fibrillation using para-hisian and ventricular pacing
79, Issue 9, Suppl A, p. 93 2022 - J American College of Cardiology
Relationship of social determinants of health and hospitalizations for atrial fibrillation: a nationwide readmissions database study
79, Issue 9, Suppl_1, p. 11-11 2022 - Circulation
Outcomes of radiofrequency transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
144, p. A14052 2021 - J American College of Cardiology
Total 30-day mortality in medicare beneficiaries following catheter ablation for atrial fibrillation (2016 -2017)
77, p. 231 2021 - Circulation
Sex-related differences in health care utilization in patients with atrial flutter 2020 - Circulation: Cardiovascular Quality and Outcomes
Population-level insights into 30-day mortality in medicare beneficiaries after inpatient and outpatient catheter ablation for atrial fibrillation
13 (Suppl_1), p. A341 2020 - J Am Coll Cardiol
Delayed versus Early Cardioversion for Patients with Uncomplicated Atrial Fibrillation Meta-Analysis
75 (11), p. 420 2020 - J American College of Cardiology
National economic cost burden of atrial flutter only patients without atrial fibrillation.
73 (Supplement 1), p. 329 2019 - J Am Coll Cardiol
Comparative variation in health care resource utilization between patients with atrial flutter only versus atrial fibrillation with or without atrial flutter.
73 (Supplement 1), p. 332 2019
Presentations
- Impact of health related social needs on sex-based differences in hospital readmissions for atrial fibrillation. Poster at the Annual Scientific Sessions for Cardiovascular Quality and Outcomes Research 2022
- Regularization of ventricular activation during atrial fibrillation using para-hisian and ventricular pacing. Poster presentation at the ACC Scientifc Sessions, Washington DC 2022
- Relationship of social determinants of health and hospitalizations for atrial fibrillation: a nationwide readmissions database study. Moderated Poster at ACC Scientifc Sessions, Washington DC. 2022
- Left ventricular lead placement using non-occlusive venogram for cardiac resynchronization therapy: a pilot study. Poster at 53rd Annual Midwest Student Biomedical Research Forum, Omaha, NE 2022
- Predictors of atrial fibrillation free survival in patients with implantable cardiac devices. Global Health Conference Midwest, Omaha, NE 2022
- Outcomes of Radiofrequency Transcatheter Ablation of Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis 2021
- Effect of post-procedural phone calls by Electrophysiology nurses on unplanned urgent care or emergency room visits after cardiac electrophysiology procedures. Poster at the ACC Annual Quality Summit 2021
- Andukuri V, Xu L, Puckrein G, Walters R, Kim MH. Total 30-day mortality in medicare beneficiaries following catheter ablation for atrial fibrillation (2016 - 2017). 2021: JACC 77 (18_Suppl 1_), 231. Presented at American College of Cardiology Annual Scientific Sessions. 2021
- Kim K, Kim S, Kim MH. Sex-related differences in health care utilization in patients with atrial flutter. Circulation 2020; 142 (Suppl_3), A12593. Presented at Annual Scientific Session of the American Heart Association. 2020
- Andukuri V, Xu L, Puckrein GA, Walters RW, Kim MH. Population-level insights into 30-day mortality in Medicare beneficiaries after inpatient and outpatient catheter ablation for atrial fibrillation. Virtual Abstract Poster Session at AHA Quality of Care and Outcomes Scientific Sessions. 2020
- American College of Cardiology Scientific Sessions Poster Presentation (Virtual): Delayed versus Early Cardioversion for Patients with Uncomplicated Atrial Fibrillation Meta-Analysis 2020
- Internal Medicine Grand Rounds: Do We Really Know Atrial Flutter: Clinical and Epidemiological Perspectives 2020
- American College of Cardiology Scientific Sessions Abstract Presentation (Poster): National Economic Cost Burden of Atrial Flutter Only Patients Without Atrial Fibrillation; New Orleans, LA 2019
- American College of Cardiology Scientific Sessions Abstract Presentation (Poster): Comparative Variation in Health Care Resource Utilization Between Patients With Atrial Flutter Only Versus Atrial Fibrillation With Or Without Atrial Flutter; New Orleans, LA 2019
- Invited Lecture: Cardiovascular Outcomes and Atrial Fibrillation; Maricopa Medical Center; Phoenix, AZ 2019
Awards
- Remarkable Reviewer Award 2021
For work on the Heart Rhythm Journal in 2020
Heart Rhythm Society - Remarkable Reviewer Award 2018
Heart Rhythm Journal - Remarkable Reviewer Award 2017
For work in 2016
Heart Rhythm Journal - Elite/Top Reviewer Award: 2014, 2015, and 2016
Awarded only to 10 or less Journal Reviewers
Journal of the American College of Cardiology - Top Grade/Best Reviewers Designation, 2012
Annals of Internal Medicine - NASPE Traveling Fellowship
North American Society of Pacing and Electrophysiology - Midwest Trainee Investigator Award
Central Society for Clinical Research